About MAGNOLIA MEDICAL TECHNOLOGIES, INC.
Magnolia Medical Technologies is a company focused on improving diagnostic accuracy in sepsis testing through its Steripath® Micro Initial Specimen Diversion Device, which is FDA 510(k)-cleared. The company is committed to reducing blood culture contamination and improving patient outcomes.
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| LAB - BLOOD CULTURE COLLECTION DEVICE AND SUPPLIES FOR A BASE YEAR + 4 OPTION YEARS | Department of Health and Human Services | $148K | |
| Federal contract award | Department of Veterans Affairs | $51K |
Is this your company?
Claim MAGNOLIA MEDICAL TECHNOLOGIES, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim MAGNOLIA MEDICAL TECHNOLOGIES, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.